Health-related quality of life and physical well-being among a 63-year-old cohort of women with androgenetic alopecia; a Finnish population-based study

Health and Quality of Life Outcomes

Volumn 3, Issue , 2005, Pages

  Hirsso, Päivi ^a,b   Rajala, Ulla ^a   Laakso, Mauri ^a,b   Hiltunen, Liisa ^a,b,c   Härkönen, Pirjo ^a,d   Keinänen Kiukaanniemi, Sirkka ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c Oulu Health Center   (Finland)

^d OULU DEACONESS INSTITUTE   (Finland)

Author keywords

Androgenic alopecia; Hair loss; Health related quality of life; Insulin resistance

Indexed keywords

GLUCOSE;

ACADEMIC ACHIEVEMENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FINLAND; HEALTH STATUS; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INSULIN RESISTANCE; MALE TYPE ALOPECIA; MARRIAGE; MEDICAL EXAMINATION; MENTAL HEALTH; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RESPONSIBILITY; VALIDATION PROCESS; WELLBEING; ALOPECIA; ANTHROPOMETRY; COHORT ANALYSIS; DAILY LIFE ACTIVITY; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SELF CONCEPT; SICKNESS IMPACT PROFILE; SOCIOECONOMICS;

ACTIVITIES OF DAILY LIVING; ALOPECIA; ANTHROPOMETRY; COHORT STUDIES; FEMALE; FINLAND; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; MOTOR ACTIVITY; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS;

EID: 27444444300     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-3-49     Document Type: Article

References (30)

1. Norwood OT: Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001, 27:53-54.
2. Cash TF, Price VH, Savin RC: Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993, 29:568-575.
3. Maffei C, Fossati A, Rinaldi F, Riva E: Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol 1994, 130:868-872.
4. van der Donk J, Passchier J, Knegt-Junk C, van der Wegen-Keijser, Nieboer C, Stolz E, Verhage F: Psychological characteristics of women with androgenetic alopecia: a controlled study. Br J Dermatol 1991, 125:248-252.
5. van der Donk J, Hunfeld JA, Passchier J, Knegt-Junk KJ, Nieboer C: Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Soc Sci Med 1994, 38:159-163.
6. Girman CJ, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J: Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med 1999, 8:1091-1095.
7. Budd D, Himmelberger D, Rhodes T, Cash TE, Girman CJ: The effects of hair loss in European men: a survey in four countries. Eur J Dermatol 2000, 10:122-127.
8. Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P: Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001, 144:1038-1043.
9. Schmidt S: Female alopecia: the mediating effect of attachment patterns on changes in subjective health indicators. Br J Dermatol 2003, 148:1205-1211.
10. Matilainen V, Koskela P, Keinanen-Kiukaanniemi S: Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000, 356:1165-1166.
11. Hirsso P, Rajala U, Hiltunen L, Laakso M, Koskela P, Härkönen P, Keinänen-Kiukaanniemi S: Association of low insulin sensitivity measured by QUICKI with hair loss in 55-year-old men. A Finnish population-based study. Diabetes Obes Metab in press.
12. Matilainen V, Laakso M, Hirsso P, Koskela P, Rajala U, Keinanen-Kiukaanniemi S: Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk 2003, 10:227-231.
13. Rajala U, Laakso M, Päivänsalo M, Pelkonen O, Suramo I, Keinänen-Kiukaanniemi S: Low Insulin sensitivity Measured by Both Quantitative Insulin Sensitivity Check Index and Homeostasis Model Assessment Method as a Risk Factor of Increased Intima-Media Thickness of the Carotid Artery. J Clin Endocrinol Metab 2002, 87:5092-5097.
14. Ludwig E: Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977, 97:237-254.
15. Aalto A-M, Aro AR, Teperi J: RAND-36 terveyteen liittyvän elämänlaadun mittarina - Mittarin Iuotettavuus Ja suomalaiset väestöarvot. In Tutkimuksia Helsinki Stakes; 1999:101.
16. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D: Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999, 15:141-155.
17. Hays RD, Morales LS: The RAND-36 measure of health-related quality of life. Ann Med 2001, 33:350-357.
18. Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0. Health Econ 1993, 2:217-227.
19. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-481.
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
21. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
22. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon ML: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
23. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002, 87:144-147.
24. Walters SJ, Campbell MJ: The use of bootstrap methods for analysing health-related quality of life outcomes (particularly the SF-36). Health Qual Life Outcomes 2004, 2:70.
25. Pi-Sunyer FX: The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002, 11:S97-S104.
26. Lesko SM, Rosenberg L, Shapiro S: A case-control study of baldness in relation to myocardial infarction in men. JAMA 1993, 269:998-1003.
27. Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE: Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med 2000, 160:165-171.
28. Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow Benno V, Keinänen-Kiukaanniemi S: Insulin resistance and depression: cross sectional study. BMJ 2005, 330:17-18.
29. Saarijarvi S, Salminen JK, Toikka T, Raitasalo R: Health-related quality of life among patients with major depression. Nord J Psychiatry 2002, 56:261-264.
30. Hemingway H, Stafford M, Stansfeld A, Shipley M, Marmot M: Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study. BMJ 1997, 315:1273-1279.